Prosecution Insights
Last updated: July 17, 2026
Application No. 18/352,377

MEMBRANE HEAT TREATMENT METHOD

Non-Final OA §103
Filed
Jul 14, 2023
Priority
Jan 28, 2021 — JP 2021-011579 +1 more
Examiner
HUANG, RYAN
Art Unit
1777
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Ngk Insulators Ltd.
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
3m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
288 granted / 552 resolved
-12.8% vs TC avg
Strong +32% interview lift
Without
With
+31.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
37 currently pending
Career history
610
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
84.2%
+44.2% vs TC avg
§102
6.8%
-33.2% vs TC avg
§112
4.6%
-35.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 552 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Applicant’s claim for the benefit of a prior-filed application (CON of PCT/JP2022/002828, filed 26 January 2022) under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Acknowledgment is made of applicant’s claim for foreign priority (JP2021-011579, filed 28 January 2021) under 35 U.S.C. 119 (a)-(d). Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-6 is/are rejected under 35 U.S.C. 103 as being unpatentable over HYODO et al. (JP 2016175063 A; machine translation provided and referenced herein). Regarding Claim 1, HYODO discloses a method for restoring the separation performance of a DDR-type zeolite membrane utilizing a thermal regeneration process (i.e., [a] membrane heat treatment method for heating a membrane; abstract). Briefly, the DDR-type zeolite membrane comprises a DDR-type zeolite with pores formed by a polyhedron containing an oxygen 8-membered ring (i.e., a membrane having small pores; pg. 3, par. 1). During treatment of a mixed fluid, compounds of the mixed fluid degrade the membrane by adhering to and depositing on the membrane surface and pores (i.e., a membrane… with adsorbates adsorbed therein; pg. 1, par. 1) to the point that the “permeation characteristics” are lowered and a regeneration process to recover the permeation characteristics is necessitated (par. spanning pg. 3-4). This regeneration process entails heating the zeolite membrane to a predetermined regeneration temperature between 100 °C and 550 °C at a temperature increasing rate of 1 °C/hr to 100 °C/hr (i.e., raising a temperature of the membrane to an intermediate heating temperature; heating and keeping said membrane at said intermediate heating temperature for a predetermined period of time; raising the temperature of said membrane to a main heating temperature that is higher than said intermediate heating temperature) for a predetermined holding time of 2 hrs to 30 hrs (i.e., heating and keeping said membrane at said main heating temperature for a predetermined period of time; pg. 4, pars. 1-2). Under such a regenerative process, the adhered/deposited compounds are desorbed and removed thereby improving membrane permeation flux (pg. 4, par. 3). HYODO is deficient in explicitly disclosing “a first recovery amount that is a difference in permeability of said membrane between after said operation b) and before said operation a) is 50% or more and 95% or less of a second recovery amount that is a difference in permeability of said membrane between after said operation d) and before said operation a)”. However, the recited limitation is directed toward an inherent result from the practice of the claimed method, i.e., because the prior art discloses or makes obvious all claimed method steps (a) through (d) as claimed, the end result of the instantly recited limitation is necessarily expected. “[T]he fact that a characteristic is a necessary feature or result of a prior-art embodiment (that is itself sufficiently described and enabled) is enough for inherent anticipation, even if that fact was unknown at the time of the prior invention.” (Toro Co. v. Deere & Co., 355 F.3d 1313, 1320, 69 USPQ2d 1584, 1590 (Fed. Cir. 2004); MPEP §2112 II). Regarding Claim 2, HYODO makes obvious the membrane heat treatment method of Claim 1. HYODO is deficient in explicitly disclosing “said permeability of said membrane after (n+ 1) times repetitions of degradation of said permeability of said membrane and said operations a) to d) is 95% or more of said permeability of said membrane after n times repetitions of degradation of said permeability of said membrane and said operations a) to d), where n is an integer greater than or equal to 1 and less than or equal to 2000”. However, the recited limitation is directed toward an inherent result from the practice of the claimed method, i.e., because the prior art discloses or makes obvious all claimed method steps (a) through (d) as claimed, the end result of the instantly recited limitation is necessarily expected. “[T]he fact that a characteristic is a necessary feature or result of a prior-art embodiment (that is itself sufficiently described and enabled) is enough for inherent anticipation, even if that fact was unknown at the time of the prior invention.” (Toro Co. v. Deere & Co., 355 F.3d 1313, 1320, 69 USPQ2d 1584, 1590 (Fed. Cir. 2004); MPEP §2112 II). Regarding Claim 3, HYODO makes obvious the membrane heat treatment method of Claim 1. HYODO further discloses the predetermined regeneration temperature is up to 550 °C from presumably room temperature (e.g., during treatment of a mixed fluid) at a temperature increasing rate of 1 °C/hr to 100 °C/hr (pg. 4, pars. 1-2). Indeed, in one example, HYODO discloses a predetermined regeneration temperature of 380 °C (pg. 5, par. 5). This implies that to reach the predetermined regeneration temperature, the temperature must be gradually increased and thereby cross the recited range of an intermediate heating temperature higher than or equal to 60 °C and lower than or equal to 180 °C and therefore, establishes a case of prima facie obviousness (MPEP 2144.05). Regarding Claim 4, HYODO makes obvious the membrane heat treatment method of Claim 1. HYODO further discloses the predetermined regeneration temperature is 380 °C (pg. 5, par. 5), which reads on the recited range of a main heating temperature is higher than or equal to 150 °C and lower than or equal to 450 °C. Regarding Claim 5, HYODO makes obvious the membrane heat treatment method of Claim 1. HYODO further discloses the DDR-type zeolite membrane comprises a DDR-type zeolite (i.e., said membrane is a zeolite membrane; pg. 3, par. 1). Regarding Claim 6, HYODO makes obvious the membrane heat treatment method of Claim 5. HYODO further discloses the DDR-type zeolite membrane comprises a DDR-type zeolite with pores formed by a polyhedron containing an oxygen 8-membered ring (i.e., said zeolite membrane is composed of a maximum 8-membered ring zeolite; pg. 3, par. 1). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: HERSHKOWITZ et al., US 7,938,886 B2; NATSUYAMA, et al., US 2022/0040673 A1; and RAVIKOVITCH, et al., US 2014/0157986 A1. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RYAN B HUANG whose telephone number is (571)270-0327. The examiner can normally be reached 9 am-5 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, In Suk Bullock can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Ryan B Huang/Primary Examiner, Art Unit 1777
Read full office action

Prosecution Timeline

Jul 14, 2023
Application Filed
May 04, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678710
LIQUID-LIQUID EXTRACTION UNIT AND MULTISTAGE LIQUID-LIQUID EXTRACTION APPARATUS USING THE SAME
4y 4m to grant Granted Jul 14, 2026
Patent 12674478
FLUID VORTEX BREAKER
3y 1m to grant Granted Jul 07, 2026
Patent 12654138
PREPARATION METHOD OF JANUS CERAMIC MEMBRANE AND APPLICATION OF JANUS CERAMIC MEMBRANE IN DISPERSION-INTENSIFIED BUBBLE AERATION PROCESS
1y 4m to grant Granted Jun 16, 2026
Patent 12649021
APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD INCLUDING CALCULATION OF PRE-BLOOD PUMP INFUSION FLOW RATE
5y 5m to grant Granted Jun 09, 2026
Patent 12643074
ELECTROLYTIC ELUENT GENERATORS WITH STABILIZED OPERATING VOLTAGES
3y 7m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
84%
With Interview (+31.5%)
3y 3m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 552 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month